Research Progress of HSP70 and Chronic Atrophic Gastritis |Biomedgrid

Chronic atrophic gastritis is still one of the main diseases threatening human health, and CAG patients have an increased risk of gastric cancer. Heat shock protein 70 protects the gastric mucosa by inhibiting the activation of protein kinase JNK and NF-kB inflammatory pathways in chronic atrophic gastritis. At present, HSP70 has been clinically used in the treatment and prevention of chronic atrophic gastritis. This article reviews the research on the relationship between HSP70 and chronic atrophic gastritis in recent years.